Zepp Health Q4 2023 Adj EPS $0.01 Misses $0.30 Estimate, Sales $84.500M Miss $675.703M Estimate
Zepp Health Q4 2023 Adj EPS $0.01 Misses $0.30 Estimate, Sales $84.500M Miss $675.703M Estimate
Zepp Health 2023年第四季度調整後每股收益0.01美元未達到0.30美元的預期，845億美元的銷售額低於6.75億美元的預期
Zepp Health (NYSE:ZEPP) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.30 by 96.67 percent. The company reported quarterly sales of $84.500 million which missed the analyst consensus estimate of $675.703 million by 87.49 percent. This is a 45.62 percent decrease over sales of $155.386 million the same period last year.
Zepp Health（紐約證券交易所代碼：ZEPP）公佈的季度收益爲每股0.01美元，比分析師普遍預期的0.30美元低96.67％。該公司公佈的季度銷售額爲845億美元，比分析師普遍預期的6.75703億美元低87.49％。這比去年同期的1.55386億美元的銷售額下降了45.62％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。